Stock Events

Stock Events

Pear Therapeutics 

$0.03
7
-$0.02-38.91% Tuesday 22:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
4.09M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

27MarExpected
Q3 2021
Q4 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-0.41
-0.26
-0.11
0.04
Expected EPS
-0.22
Actual EPS
0

Financials

-594.7%Profit Margin
Unprofitable
2020
2021
2022
12.69MRevenue
-75.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PEAR. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers digital health solutions and medical devices that compete in the therapeutic area similar to Pear Therapeutics.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories provides a range of healthcare solutions including digital therapeutic platforms that rival Pear Therapeutics' offerings.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical and medical devices segments, develops products that can be seen as alternatives to those offered by Pear Therapeutics.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is involved in digital health and biopharmaceuticals which competes with Pear Therapeutics in providing therapeutic solutions.
Novartis
NVS
Mkt Cap237.61B
Novartis focuses on innovative healthcare solutions including digital therapeutics, directly competing with Pear Therapeutics.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific operates in the life sciences field, offering products and services that can compete with the digital therapeutic solutions from Pear Therapeutics.
Dexcom
DXCM
Mkt Cap22.71B
Dexcom, specializing in glucose monitoring systems, competes in the broader digital health market where Pear Therapeutics is also positioned.
Siemens
SIEGY
Mkt Cap224.45B
Siemens Healthineers offers a wide range of medical technology and digital solutions that compete with Pear Therapeutics' digital health products.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG develops digital health solutions and medical devices that can be used as alternatives to Pear Therapeutics' products.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation, known for medical technologies, competes in the digital and therapeutic solutions space overlapping with Pear Therapeutics' market.

About

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
Show more...
CEO
Employees
298
Country
US
ISIN
US7047231052

Listings

0 Comments

Share your thoughts

FAQ

What is Pear Therapeutics stock price today?▼
The current price of PEAR is $0.03 USD — it has decreased by -38.91% in the past 24 hours. Watch Pear Therapeutics stock price performance more closely on the chart.
What is Pear Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pear Therapeutics stocks are traded under the ticker PEAR.
What is Pear Therapeutics market cap?▼
Today Pear Therapeutics has the market capitalization of 4.09M
What were Pear Therapeutics earnings last quarter?▼
PEAR earnings for the last quarter are 0 USD per share, whereas the estimation was -0.22 USD resulting in a +100% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pear Therapeutics revenue for the last year?▼
Pear Therapeutics revenue for the last year amounts to 12.69M USD.
What is Pear Therapeutics net income for the last year?▼
PEAR net income for the last year is -75.49M USD.
How many employees does Pear Therapeutics have?▼
As of April 02, 2026, the company has 298 employees.
In which sector is Pear Therapeutics located?▼
Pear Therapeutics operates in the Professional, Scientific, and Technical Services sector.
When did Pear Therapeutics complete a stock split?▼
Pear Therapeutics has not had any recent stock splits.